Shares of BWX Technologies Inc. (BWXT) took a dip on Monday, falling about 3.3% after the company made a move to bulk up its nuclear business. They’re buying Precision Components Group—that includes Precision Custom Components and DC Fabricators—to strengthen their U.S. commercial nuclear footprint. Financial terms weren’t disclosed, but PCG brought in around $125 million in revenue last year and will join BWXT’s Commercial Operations segment, keeping its existing facilities running.

Think of it as BWXT adding more muscle to its manufacturing arm. The deal brings over 500,000 square feet of extra space and more than 400 employees, boosting capabilities in areas like machining, welding, and pressure vessels. It’s expected to close in the second half of 2026, pending regulatory nods, and PCG will keep supporting programs for clients like Electric Boat and Bechtel Plant Machinery, along with other U.S. Navy work.

Why does this matter? Well, BWXT’s executives are framing it as a strategic step to meet growing demand. "This acquisition builds on BWXT's strong performance in the commercial nuclear industry and represents an important first step as we establish U.S.-based commercial nuclear manufacturing capacity to meet the accelerating needs of U.S. commercial nuclear customers," said John MacQuarrie, president of BWXT Commercial Operations. CEO Rex D. Geveden added that it "creates an immediate commercial manufacturing footprint for BWXT that complements our existing service offerings to U.S. customers and fully leverages our commercial engineering expertise and supplier base." The company had cash and equivalents of $499.779 million as of December 2025, so they’ve got some dry powder for deals like this.

Now, let’s talk about the stock. Despite today’s drop, BWXT has been on a tear—up 127.75% over the past year. It’s trading 3.9% above its 20-day simple moving average and 9.3% above its 50-day, which suggests short-term momentum is still pretty strong. The relative strength index sits at 63.01, right in that neutral zone where it’s neither overbought nor oversold, so there’s room to move in either direction. Key levels to watch: resistance at the 52-week high of $241.82 and support around $189.00, where buyers might step in.

Earnings are coming up on May 4, 2026, and analysts are looking for 92 cents per share (up from 91 cents) and revenue of $831.55 million (up from $682.26 million). With a P/E of 65.9x, the valuation is on the premium side, reflecting high expectations. The analyst consensus is a Buy rating with an average price target of $169.51, but recent moves show a split view: Wells Fargo initiated with Underweight and a $200 target on April 1, B of A Securities raised its target to $250 with a Buy on March 25, and TD Securities started coverage with a Buy and $230 target on March 12.

So, what’s the takeaway? BWXT is investing to grow its nuclear capacity, which could pay off long-term, but investors seem a bit cautious today, maybe waiting to see how it all shakes out in the earnings report next month. Keep an eye on those technical levels and the upcoming numbers—they’ll tell us more about whether this dip is a buying opportunity or a sign of things cooling off.